Rosalind Advisors, Inc. 13D/13G Filings for Galera Therapeutics, Inc. (GRTX)

Rosalind Advisors, Inc. 13D and 13G filings for Galera Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
5:14 pm
Purchase
2022-02-0413GGalera Therapeutics, Inc.
GRTX
Rosalind Advisors, Inc.1,543,783
5.800%
1,543,783increase
(New Position)
Filing